HROW PEER ANALYSIS

Harrow Health Inc — metric-by-metric comparison with peers and the industry median

HROWHarrow Health Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

HROWIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	HROW	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
P/E	—	—	—	46.82	22.08●	31.28	21.37
P/B	55.43	-0.88●	0.80	3.47	4.32	1.98	1.82
EV/EBITDA	57.12	4.05●	33.84	14.07	14.64	19.15	12.26
P/S	5.92	0.21●	5.03	1.86	3.93	3.94	2.09

Financial Health
Metric	HROW	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Current Ratio	2.48	1.32	1.73	1.33	3.66●	0.92	2.22
Debt/Equity	1,047.4%	-1,010.0%●	5.9%	41.0%	17.0%	52.3%	46.3%
NetDebt/EBITDA	6.55	3.71	-0.10●	1.10	0.09	3.50	1.24

Profitability
Metric	HROW	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Net Margin	-5.6%	-13.5%	-3.6%	4.0%	17.8%●	12.6%	4.0%
ROE	-35.1%	—	-0.6%	8.7%	20.9%●	6.3%	6.4%
ROA	-3.8%	-4.7%	-0.5%	4.8%	15.1%●	3.2%	3.4%
EBITDA Margin	11.7%	60.0%●	14.8%	14.3%	27.0%	25.2%	18.2%

Growth + Dividend
Metric	HROW	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Rev. Growth	26.2%●	-9.9%	-2.3%	16.3%	-3.4%	-26.7%	7.5%
NI Growth	—	—	—	146.6%●	-5.9%	-14.2%	5.0%
Div. Yield	—	0.0%	2.6%●	0.0%	1.6%	2.0%	2.0%
Payout	—	0.0%	-365.1%	0.0%	36.3%	40.0%	0.8%

Valuation
Metric	HROW	PRGO	COLL	XERS	ANIP	PAHC	Ind. Median
P/E	—	—	19.80	122.48	20.67	14.33●	21.37
P/B	55.43	0.61●	4.75	113.04	3.30	3.77	1.82
EV/EBITDA	57.12	—	3.07●	30.27	7.97	9.21	12.26
P/S	5.92	0.37●	1.86	4.67	2.01	0.91	2.09

Financial Health
Metric	HROW	PRGO	COLL	XERS	ANIP	PAHC	Ind. Median
Current Ratio	2.48	2.72	1.71	2.12	3.12	3.17●	2.22
Debt/Equity	1,047.4%	152.3%	258.6%	286.9%	58.3%●	217.6%	46.3%
NetDebt/EBITDA	6.55	-2.78●	0.63	-1.61	0.07	3.15	1.24

Profitability
Metric	HROW	PRGO	COLL	XERS	ANIP	PAHC	Ind. Median
Net Margin	-5.6%	-43.5%	9.4%	3.8%	9.7%●	6.3%	4.0%
ROE	-35.1%	-53.0%	27.4%	—	17.8%	30.3%●	6.4%
ROA	-3.8%	-20.5%	4.6%	3.4%	6.6%	6.9%●	3.4%
EBITDA Margin	11.7%	-29.7%	76.6%●	14.7%	25.4%	15.0%	18.2%

Growth + Dividend
Metric	HROW	PRGO	COLL	XERS	ANIP	PAHC	Ind. Median
Rev. Growth	26.2%	-3.6%	19.9%	41.5%●	37.0%	26.0%	7.5%
NI Growth	—	—	70.7%	—	—	199.6%●	5.0%
Div. Yield	—	11.3%●	—	—	0.0%	1.5%	2.0%
Payout	—	-8.7%	—	—	0.8%	20.4%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on HROW

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.